Assessing the content and quality of information on the treatment of postmenopausal osteoporosis on the World Wide Web

Gynecological Endocrinology

Volumn 22, Issue 12, 2006, Pages 669-675

  Pérez López, Faustino R ^a,b   Pérez Roncero, Gonzalo R ^a  

^a Zaragoza Gynecological Institute   (Spain)

^b Instituto Ginecológico de Zaragoza   (Spain)

Author keywords

Bisphosphonates; Calcitonin; Calcium; Google; Hormone replacement therapy; Internet; Osteoporosis; Raloxifene; Teriparatide; Vitamin D; World Wide Web

Indexed keywords

ARTICLE; CONSUMER; FACTUAL DATABASE; GOVERNMENT; INTERNET; MEDICAL INFORMATION; MEDICAL INFORMATION SYSTEM; MEDICAL LITERATURE; ORGANIZATION; PEER REVIEW; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; TREATMENT OUTCOME;

DATABASES, FACTUAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INFORMATION SERVICES; INTERNET; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT EDUCATION; PEER REVIEW, RESEARCH; WOMEN'S HEALTH;

EID: 33845605428     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590601012603     Document Type: Article

References (55)

1. Hodson J, Marsh J. Predictors of postmenopausal osteoporosis. Br Med J 2003;327:392-393.
2. Reginster JY, Ben Sedrine W, Viethel P, Micheletti MC, Chevallier T, Audran M. Validation of OSIRIS, a prescreening tool for the identification of women with an increased risk of osteoporosis. Gynecol Endocrinol 2004;18:3-8.
3. Zwart Salmerón M, Fradera Vilalta M, Solanas Saura P, González Pastor C, Adalid Vilar C. Management of osteoporosis at a primary care center. Aten Primaria 2004;33:183-187.
4. Riggs BL, Hodgson SF, O'Fallon WM, Chao EY, Wahner HW, Muhs JM, Cedel SL, Melton LJ 3rd. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990;322:801-809.
5. Chesnut CH 3rd, Silverman S, Andriano K, Genant H, Gimona A, Harris S, Kiel D, LeBoff M, Maricic M, Miller P, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med 2000;109:267-276.
6. Delmas PD. Treatment of postmenopausal osteoporosis. Lancet 2002;359:2018-2026.
7. Hauselmann HJ, Rizzoli R. A comprehensive review of treatments for postmenopausal osteoporosis. Osteoporos Int 2003;14:2-12.
8. Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C. Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Summary of meta-analysis of therapies for postmenopausal osteoporosis. Endocr Rev 2002;23:570-578.
9. Nguyen TV, Center JR, Eisman JA. Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust 2004;180(5 Suppl):S18-S22.
10. Seeman E, Eisman JA. 7: Treatment of osteoporosis: why, whom, when and how to treat. Med J Aust 2004;180: 298-303.
11. Johnell O, Kanis JA, Black DM, Balogh A, Poor G, Sarkar S, Zhou C, Pavo I. Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study. J Bone Miner Res 2004;19:764-772.
12. Cheung AM, Feig DS, Kapral M, Diaz-Granados N, Dodin S; Canadian Task Force on Preventive Health Care. Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care. Can Med Assoc J 2004;170:1665-1667.
13. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis [Internet]. Washington (DC): National Osteoporosis Foundation; 2003 [cited 2004 Sep 3] p 37. Available form: http://www.nof.org/ physguide.
14. Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, Johnston CC Jr, Kleerekoper M, Lindsay R, Luckey MM, et al., AACE Osteoporosis Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 2003;9:544-564.
15. Wehren LE, Hosking D, Hochberg MC. Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis. Curr Med Res Opin 2004;20:525-531.
16. Boonen S, Rizzoli R, Meunier PJ, Stone M, Nuki G, Syversen U, Lehtonen-Veromaa M, Lips P, Johnell O, Reginster JY. The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporos Int 2004;15:511-519.
17. Kessel B. Hip fracture prevention in postmenopausal women. Obstet Gynecol Surv 2004;59:446-455.
18. Ringa V. Alternatives to hormone replacement therapy for menopause: an epidemiological evaluation. J Gynecol Obstet Biol Reprod (Paris) 2004;33:195-209.
19. Barthel HR, Scharla SH. Benefits beyond the bones - vitamin D against falls, cancer, hypertension and autoimmune diseases. Dtsch Med Wochenschr 2003;128:440-446.
20. Vanchieri C. Studies shedding light on vitamin D and cancer. J Natl Cancer Inst 2004;96:735-736.
21. Wallace K, Baron JA, Cole BF, Sandler RS, Karagas MR, Beach MA, Haile RW, Burke CA, Pearson LH, Mandel JS, et al. Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst 2004;96:921-925.
22. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68(Suppl):1375S-1379S.
23. Wangen KE, Duncan AM, Merz-Demlow BE, Xu X, Marcus R, Phipps WR, Kurzer MS. Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 2000;85:3043-3048.
24. Chiechi LM, Secreto G, D'Amore M, Fanelli M, Venturelli E, Cantatore F, Valerio T, Laselva G, Loizzi P. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitas 2002;42:295-300.
25. Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K. Soy product intake and serum isoflavonoid and estradiol concentrations in relation to bone mineral density in postmenopausal Japanese women. Osteoporos Int 2002;13: 200-204.
26. Knudson Schult TM, Ensrud KE, Blackwell T, Ettinger B, Wallace R, Tice JA. Effect of isoflavones on lipids and bone turnover markers in menopausal women. Maturitas 2004;18: 209-218.
27. Brixen KT, Christensen B, Ejersted C, Langdahl BL. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis. Basic Clin Pharmacol Toxicol 2004;94:260-270.
28. Cappuzzo KA, Delafuente JC. Teriparatide for severe osteoporosis. Ann Pharmacother 2004;38:294-302.
29. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Povs-Nielsen S, Rizzoli R, Genant HK, Reginster JY. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. Obstet Gynecol Surv 2004;59:526-527.
30. Bonaiuti D, Shea B, Iovine R, Negrini S, Robinson V, Kemper H, Wells G, Tugwell P, Cranney A. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev 2002;(3): CD000333.
31. Parker MJ, Gillespie WJ, Gillespie LD. Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review. Br Med J 2006;332:571-574.
32. Reed M, Anderson C. Evaluation of patient information Internet web sites about menopause and hormone replacement therapy. Maturitas 2002;43:135-154.
33. Pérez-López FR. An evaluation of the contents and quality of menopause information on the World Wide Web. Maturitas 2004;49:276-282.
34. Dvorak JC. Search engine mania. The mad rush to develop new ways of finding info online. PC Magazine [Internet]. March 2004 issue [accessed 12 August 2006]. Available from: http://www.findarticles.com/p/articles/mi_zdpcm/ is_200403/ai_ziff122865.
35. Page Rank. Wikipedia: The Free Encyclopedia. Available from: http://en.wikipedia.org/wiki/Page_rank [accessed 12 August 2006].
36. Bin L, Lun K. The retrieval effectiveness of medical information on the web. Int J Med Informatics 2001;62:155-163.
37. Meric F, Bernstam EV, Mirza NQ, Hunt KK, Ames FC, Ross MI, Kuerer HM, Pollock RE, Musen MA, Singletary SE. Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites. Br Med J 2002;324:577-581.
38. Sandvik H. Health information and interaction on the internet: a survey of female urinary incontinence. Br Med J 1999;319:29-32.
39. Silberg WM, Lundberg GD, Musacchio RA. Assessing, controlling, and assuring the quality of medical information on the internet. J Am Med Assoc 1997;277:1244-1245.
40. HON Code of Conduct (HONcode) for medical and health web sites [Internet]. Available from: http://www.hon.ch/ HONcode/Conduct.html [accessed 12 August 2006].
41. Segal E, Tamir A, Ish-Shalom S. Compliance of osteoporotic patients with different treatment regimens. Isr Med Assoc J 2003;5:859-862.
42. McCombs JS, Thiebaud P, McLaughlin-Miley C, Shi J. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 2004;48:271-287.
43. Cerulli J, Zeolla MM. Impact and feasibility of a community pharmacy bone mineral density screening and education program. J Am Pharm Assoc (Wash DC) 2004;44:161-167.
44. Kulp JL, Rane S, Bachmann G. Impact of preventive osteoporosis education on patient behaviour: immediate and 3-month follow-up. Menopause 2004;11:116-119.
45. Hanif F, Sivaprakasam R, Butler A, Huguet E, Pettigrew GJ, Michael ED, Praseedom RK, Jamieson NV, Bradley JA, Gibbs P. Information about liver transplantation on the World Wide Web. Med Inform Internet Med 2006;31:153-160.
46. Eysenbach G, Köhler C. How do consumers search for and appraise health information on the world wide web? Qualitative study using focus groups, usability tests, and in-depth interviews. Br Med J 2002;324:573-577.
47. Brin S, Page L. The anatomy of a large-scale hypertextual web search engine. Available from: http://www-db.stanford. edu/~backrub/google.html [accessed 12 August 2006].
48. Sullivan D. How search engines rank web pages. Sear Engine Watch, 31 July 2006. Available from: http://searchenginewatch. com/showPage.html?page=2167961 [accessed 12 August 2006].
49. Dyer C. Internet sales of prescription drugs investigated. Br Med J 1996;313:645.
50. Smith A. Evaluation of information sources [Internet]. Available from: http://www.vuw.ac.nz/staff/alastair_smith/evaln/evaln. htm [accessed 23 August 2006].
51. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. J Am Med Assoc 1997;277:927-934.
52. Wyatt JC. Commentary: measuring quality and impact of the world wide web. Br Med J 1997;314:1879-1881.
53. Schmidt K, Ernst E. Assessing websites on complementary and alternative medicine for cancer. Ann Oncol 2004;15:733-742.
54. Dutta-Bergman MJ. Health attitudes, health cognitions, and health behaviours among Internet health information seekers: population-based survey. J Med Internet Res 2004;6:e15.
55. Abbasi K, Butterfield M, Connor J, Delamothe T, Dutton S, Hadridge P, Horgan A, Smith J, Smith R, Walford E, et al. Four futures for scientific and medical publishing. Br Med J 2002;325:1472-1475.